Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:00 pm Sale | 2023-12-19 | 13G | 89BIO INC ETNB | Cormorant Asset Management, LP | 0 0.000% | -2,550,000 (Position Closed) | Filing History |
| 2024-01-30 4:41 pm Sale | 2023-11-29 | 13D | ERASCA INC ERAS | Cormorant Asset Management, LP | 0 0.000% | -10,893,107 (Position Closed) | Filing History |
| 2023-12-14 4:04 pm Purchase | 2023-12-04 | 13G | EYEPOINT INC EYPT | Cormorant Asset Management, LP | 6,038,235 12.360% | 6,038,235 (New Position) | Filing History |
| 2023-11-16 4:02 pm Purchase | 2023-11-06 | 13G | KORRO BIO INC KRRO | Cormorant Asset Management, LP | 679,170 8.490% | 679,170 (New Position) | Filing History |
| 2023-11-13 4:03 pm Purchase | 2023-11-01 | 13G | VYNE THERAPEUTICS INC VYNE | Cormorant Asset Management, LP | 1,394,336 9.990% | 1,394,336 (New Position) | Filing History |
| 2023-11-06 4:01 pm Purchase | 2023-10-25 | 13G | HARPOON THERAPEUTICS INC HARP | Cormorant Asset Management, LP | 1,678,619 9.900% | 1,678,619 (New Position) | Filing History |
| 2023-10-23 4:02 pm Purchase | 2023-10-11 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Cormorant Asset Management, LP | 2,850,000 5.790% | 2,850,000 (New Position) | Filing History |
| 2023-10-13 4:00 pm Purchase | 2023-10-03 | 13G | ALX ONCOLOGY HLDGS INC ALXO | Cormorant Asset Management, LP | 3,142,079 6.310% | 3,142,079 (New Position) | Filing History |
| 2023-10-10 4:01 pm Purchase | 2023-09-29 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Cormorant Asset Management, LP | 2,800,000 5.530% | 2,800,000 (New Position) | Filing History |
| 2023-04-24 5:26 pm Purchase | 2023-04-20 | 13G | IMMUNEERING CORP IMRX | Cormorant Asset Management, LP | 4,204,364 14.420% | 1,918,183 (+83.90%) | Filing History |
| 2023-03-13 4:00 pm Purchase | 2023-03-03 | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Cormorant Asset Management, LP | 52,500,000 17.730% | 36,145,298 (+221.01%) | Filing History |
| 2023-02-14 3:15 pm Sale | 2022-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | Cormorant Asset Management, LP | 1,952,032 8.380% | -31,136 (-1.57%) | Filing History |
| 2023-02-14 3:14 pm Sale | 2022-12-31 | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management, LP | 5,150,000 9.210% | -290,451 (-5.34%) | Filing History |
| 2023-02-14 3:13 pm Sale | 2022-12-31 | 13G | GREENLIGHT BIOSCIENCES HLDGS P GRNA | Cormorant Asset Management, LP | 9,188,659 6.060% | -290,399 (-3.06%) | Filing History |
| 2023-02-14 3:13 pm Purchase | 2022-12-31 | 13G | IMMUNEERING CORP IMRX | Cormorant Asset Management, LP | 2,286,181 8.660% | 33,553 (+1.49%) | Filing History |
| 2023-02-14 3:12 pm Sale | 2022-12-31 | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Cormorant Asset Management, LP | 16,354,702 6.050% | -911,442 (-5.28%) | Filing History |
| 2023-02-14 3:11 pm Sale | 2022-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Cormorant Asset Management, LP | 2,893,717 5.980% | -108,483 (-3.61%) | Filing History |
| 2023-02-14 3:10 pm Purchase | 2022-12-31 | 13G | BIOATLA INC BCAB | Cormorant Asset Management, LP | 73,607 7.980% | 32,843 (+80.57%) | Filing History |
| 2023-02-14 3:10 pm Purchase | 2022-12-31 | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management, LP | 55,918 7.950% | 3,613 (+6.91%) | Filing History |
| 2023-02-14 3:09 pm Sale | 2022-12-31 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management, LP | 1,971,739 6.770% | -28,261 (-1.41%) | Filing History |